Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Badve SV, Bilal A, Lee MMY, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00271-7.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Badve SV, Bilal A, Lee MMY, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00271-7.
Leggi
Hennekes MHCL, Haugvik S, de Wit M, et al.
Diabetes Care. 2024:dc241599.
Leggi
Hennekes MHCL, Haugvik S, de Wit M, et al.
Diabetes Care. 2024:dc241599.
Leggi
Slebe R, Splinter JJ, Schoonmade LJ, et al.
Diabetes Obes Metab. Pub. online 28 Nov 2024.
Leggi
Tricò D, Sacchetta L, Rebelos E, et al.
Diabetologia. Pub. online 29 Nov 2024.
Leggi
Günther K, Pflüger M, Eiben G, et al.
Nutr Metab Cardiovasc Dis. Pub. online 30 Nov 2024.
Leggi
Shah R, Finlay AY, Ali FM, et al.
Diabetes Obes Metab. Pub. online 24 Nov 2024.
Leggi
Saad Cleto A, Schirlo JM, Oliveira Gomes VH, et al.
Diabetes Obes Metab. Pub. online 25 Nov 2024.
Leggi
le Roux CW, Steen O, Lucas KJ, et al.
Diabetes Obes Metab. Pub. online 25 Nov 2024.
Leggi
Bjarkø VV, Haug EB, Langhammer A, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004493.
Leggi